These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 39056399)

  • 1. Tofacitinib in Pediatric Alopecia Areata Totalis and Alopecia Universalis: A Retrospective Analysis From India.
    Gowda SK; Aggarwal A; Thakur V; Behera B; Garg S; Sethy M; Ayyanar P
    J Cutan Med Surg; 2024 Jul; ():12034754241266128. PubMed ID: 39056399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis.
    Sharath S; Sardana K; Khurana A
    Indian Dermatol Online J; 2024; 15(1):49-54. PubMed ID: 38282998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of efficacy and safety of tofacitinib and azathioprine in patients with alopecia areata and variants: a double-blind, randomized controlled trial.
    Paracha M; Wasim M; Noor SM; Khan AQ; Sagheer F; Ahmad I
    Arch Dermatol Res; 2024 Jul; 316(7):458. PubMed ID: 38967866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Janus kinase inhibitors for alopecia areata.
    King BA; Craiglow BG
    J Am Acad Dermatol; 2023 Aug; 89(2S):S29-S32. PubMed ID: 37591562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A Promising Therapy for the Treatment of Alopecia Areata: A Case Report of Six Patients.
    Shivanna CB; Shenoy C; Priya RA
    Int J Trichology; 2018; 10(3):103-107. PubMed ID: 30034188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata.
    Kennedy Crispin M; Ko JM; Craiglow BG; Li S; Shankar G; Urban JR; Chen JC; Cerise JE; Jabbari A; Winge MC; Marinkovich MP; Christiano AM; Oro AE; King BA
    JCI Insight; 2016 Sep; 1(15):e89776. PubMed ID: 27699252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients.
    Liu LY; Craiglow BG; Dai F; King BA
    J Am Acad Dermatol; 2017 Jan; 76(1):22-28. PubMed ID: 27816293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical response to oral tofacitinib in pediatric patients with alopecia areata.
    Youssef S; Bordone LA
    JAAD Case Rep; 2023 Jan; 31():83-88. PubMed ID: 36545483
    [No Abstract]   [Full Text] [Related]  

  • 9. Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.
    Almutairi N; Nour TM; Hussain NH
    Dermatology; 2019; 235(2):130-136. PubMed ID: 30566941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population.
    AlMarzoug A; AlOrainy M; AlTawil L; AlHayaza G; AlAnazi R; AlIssa A; AlSheikh A; AlKhalifah A; AlHarithy R
    Int J Dermatol; 2022 Jul; 61(7):886-894. PubMed ID: 34716573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ritlecitinib: an investigational drug for the treatment of moderate to severe alopecia areata.
    Eisman S; Sinclair R
    Expert Opin Investig Drugs; 2021 Dec; 30(12):1169-1174. PubMed ID: 34826225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib-A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata.
    Kołcz K; Żychowska M; Sawińska E; Reich A
    Dermatol Ther (Heidelb); 2023 Mar; 13(3):843-856. PubMed ID: 36639612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of severe alopecia areata with baricitinib.
    Olamiju B; Friedmann A; King B
    JAAD Case Rep; 2019 Oct; 5(10):892-894. PubMed ID: 31681829
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel investigational drugs for alopecia areata and future perspectives.
    Chim I; Ghiya R; Sinclair RD; Eisman S
    Expert Opin Investig Drugs; 2024 May; 33(5):441-449. PubMed ID: 38682280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world experience and long-term evaluation of tofacitinib in refractory alopecia areata: A prospective, open-label, single-center study in Asian Arab population.
    Husein-ElAhmed H; Abdulla N; Al-Obaidli A; Ali-Alam M; Steinhoff M
    Dermatol Ther; 2022 Dec; 35(12):e15871. PubMed ID: 36177791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with oral tofacitinib in severe alopecia areata with different clinical responses.
    Dincer Rota D; Emeksiz MAC; Erdogan FG; Yildirim D
    J Cosmet Dermatol; 2021 Sep; 20(9):3026-3033. PubMed ID: 33533091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study.
    Shin JW; Huh CH; Kim MW; Lee JS; Kwon O; Cho S; Park HS
    Acta Derm Venereol; 2019 Jan; 99(1):41-46. PubMed ID: 30281139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of alopecia areata in pre-adolescent children with oral tofacitinib: A retrospective study.
    Jerjen R; Meah N; Trindade de Carvalho L; Wall D; Eisman S; Sinclair R
    Pediatr Dermatol; 2021 Jan; 38(1):103-108. PubMed ID: 33099833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European expert consensus statement on the systemic treatment of alopecia areata.
    Rudnicka L; Arenbergerova M; Grimalt R; Ioannides D; Katoulis AC; Lazaridou E; Olszewska M; Ovcharenko YS; Piraccini BM; Prohic A; Rakowska A; Reygagne P; Richard MA; Soares RO; Starace M; Vañó-Galvan S; Waskiel-Burnat A
    J Eur Acad Dermatol Venereol; 2024 Apr; 38(4):687-694. PubMed ID: 38169088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors.
    Paggioli I; Moss J
    J Autoimmun; 2022 Dec; 133():102926. PubMed ID: 36335798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.